• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
The Evaluation of Hematological Parameters and Their Correlation with Disease Prognosis in COVID-19 Disease in Iran.伊朗COVID-19疾病血液学参数评估及其与疾病预后的相关性
Int J Hematol Oncol Stem Cell Res. 2023 Apr 1;17(2):89-99. doi: 10.18502/ijhoscr.v17i2.12645.
2
Identification of hematological and inflammatory parameters associated with disease severity in hospitalized patients of COVID-19.新冠病毒肺炎住院患者中与疾病严重程度相关的血液学和炎症参数的识别
J Family Med Prim Care. 2022 Jan;11(1):260-264. doi: 10.4103/jfmpc.jfmpc_941_21. Epub 2022 Jan 31.
3
The predictive and prognostic role of hematologic and biochemical parameters in the emergency department among coronavirus disease 2019 patients.血液学和生化学参数在 2019 年冠状病毒病患者急诊科的预测和预后作用。
Chin J Physiol. 2021 Nov-Dec;64(6):306-311. doi: 10.4103/cjp.cjp_77_21.
4
Covid-19: contribution of clinical characteristics and laboratory features for early detection of patients with high risk of severe evolution.Covid-19:临床特征和实验室特征对早期发现高危重症患者的贡献。
Acta Clin Belg. 2022 Apr;77(2):261-267. doi: 10.1080/17843286.2020.1822078. Epub 2020 Sep 16.
5
Evaluation of inflammatory and hematological parameters in patients diagnosed with COVID-19.对确诊为新型冠状病毒肺炎患者的炎症和血液学参数进行评估。
J Infect Dev Ctries. 2022 Oct 31;16(10):1564-1569. doi: 10.3855/jidc.14341.
6
A biological profile for diagnosis and outcome of COVID-19 patients.用于 COVID-19 患者诊断和预后的生物学特征。
Clin Chem Lab Med. 2020 Oct 15;58(12):2141-2150. doi: 10.1515/cclm-2020-0626.
7
Neutrophil to lymphocytic ratio and other inflammatory markers as adverse outcome predictor in hospitalized COVID-19 patients.中性粒细胞与淋巴细胞比值和其他炎症标志物可预测住院 COVID-19 患者的不良结局。
Egypt J Immunol. 2022 Apr;29(2):57-67.
8
Laboratory biomarker predictors for disease progression and outcome among Egyptian COVID-19 patients.埃及 COVID-19 患者疾病进展和结局的实验室生物标志物预测因子。
Int J Immunopathol Pharmacol. 2022 Jan-Dec;36:3946320221096207. doi: 10.1177/03946320221096207.
9
Hematological and other Laboratory Parameter Changes in COVID-19 Patients.新型冠状病毒肺炎患者的血液学和其他实验室参数变化。
J Assoc Physicians India. 2023 Apr;71(4):11-12. doi: 10.5005/japi-11001-0200.
10
Hematological Profile with Peripheral Blood Smear Morphology of Admitted COVID-19 Infected Patients: A Study at a COVID Dedicated Hospital in Kashmir.收治 COVID-19 感染患者的血液学特征和外周血涂片形态:克什米尔的一家 COVID 定点医院的研究。
J Assoc Physicians India. 2022 Dec;70(12):11-12. doi: 10.5005/japi-11001-0149.

本文引用的文献

1
Pathogenic T-cells and inflammatory monocytes incite inflammatory storms in severe COVID-19 patients.致病性T细胞和炎性单核细胞在重症COVID-19患者中引发炎症风暴。
Natl Sci Rev. 2020 Jun;7(6):998-1002. doi: 10.1093/nsr/nwaa041. Epub 2020 Mar 13.
2
Evaluation of hematological parameters as an indicator of disease severity in Covid-19 patients: Pakistan's experience.评估血液学参数作为新冠患者疾病严重程度的指标:来自巴基斯坦的经验。
J Clin Lab Anal. 2021 Jun;35(6):e23809. doi: 10.1002/jcla.23809. Epub 2021 May 24.
3
COVID-19 diagnosis -A review of current methods.新型冠状病毒肺炎诊断——当前方法综述
Biosens Bioelectron. 2021 Jan 15;172:112752. doi: 10.1016/j.bios.2020.112752. Epub 2020 Oct 24.
4
Prolonged prothrombin time at admission predicts poor clinical outcome in COVID-19 patients.入院时凝血酶原时间延长预示着COVID-19患者临床预后不良。
World J Clin Cases. 2020 Oct 6;8(19):4370-4379. doi: 10.12998/wjcc.v8.i19.4370.
5
Differences of inflammatory and non-inflammatory indicators in Coronavirus disease-19 (COVID-19) with different severity.新型冠状病毒病(COVID-19)不同严重程度的炎症和非炎症指标的差异。
Infect Genet Evol. 2020 Nov;85:104511. doi: 10.1016/j.meegid.2020.104511. Epub 2020 Aug 26.
6
An inflammatory cytokine signature predicts COVID-19 severity and survival.炎症细胞因子特征可预测 COVID-19 严重程度和存活情况。
Nat Med. 2020 Oct;26(10):1636-1643. doi: 10.1038/s41591-020-1051-9. Epub 2020 Aug 24.
7
Diagnostic and prognostic value of hematological and immunological markers in COVID-19 infection: A meta-analysis of 6320 patients.COVID-19 感染患者血液学和免疫学标志物的诊断和预后价值:6320 例患者的荟萃分析。
PLoS One. 2020 Aug 21;15(8):e0238160. doi: 10.1371/journal.pone.0238160. eCollection 2020.
8
Anemia and iron metabolism in COVID-19: a systematic review and meta-analysis.新型冠状病毒肺炎与铁代谢及贫血的关系:系统评价和荟萃分析。
Eur J Epidemiol. 2020 Aug;35(8):763-773. doi: 10.1007/s10654-020-00678-5. Epub 2020 Aug 20.
9
Anemia is associated with severe illness in COVID-19: A retrospective cohort study.贫血与 COVID-19 重症相关:一项回顾性队列研究。
J Med Virol. 2021 Mar;93(3):1478-1488. doi: 10.1002/jmv.26444. Epub 2020 Nov 10.
10
D-dimer as a biomarker for disease severity and mortality in COVID-19 patients: a case control study.D-二聚体作为COVID-19患者疾病严重程度和死亡率的生物标志物:一项病例对照研究。
J Intensive Care. 2020 Jul 10;8:49. doi: 10.1186/s40560-020-00466-z. eCollection 2020.

伊朗COVID-19疾病血液学参数评估及其与疾病预后的相关性

The Evaluation of Hematological Parameters and Their Correlation with Disease Prognosis in COVID-19 Disease in Iran.

作者信息

Shahi Farhad, Safaee Nodehi Sayyed Reza, Fekrvand Saba, Fathi Fatemeh, Dabiri Mohammad Reza, Abdollahi Alireza, Hosseini Hanieh

机构信息

Breast Disease Research Center, Tehran University of Medical Sciences, Tehran, Iran.

Department of Internal Medicine, Hematology and Medical Oncology Ward, Cancer Research Center, Cancer Institute, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran.

出版信息

Int J Hematol Oncol Stem Cell Res. 2023 Apr 1;17(2):89-99. doi: 10.18502/ijhoscr.v17i2.12645.

DOI:10.18502/ijhoscr.v17i2.12645
PMID:37637772
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10452951/
Abstract

Since 2019, Coronavirus has been a highly contagious disease. The COVID-19 outbreak was declared a pandemic by the World Health Organization in March 2020. Variable laboratory findings are reported in COVID-19 patients, among which elevated levels of D-dimer, lactate dehydrogenase, as well as lymphopenia, have been reported to be associated with increased severity of disease symptoms requiring ventilator support, intensive care unit admission, and mortality. In the current study, inclusion criteria were: patient age above 18 years and hospitalization in the Imam Khomeini hospital with COVID-19 disease confirmed with nasopharyngeal swab polymerase chain reaction tests. Levels of white blood cells, neutrophils, lymphocytes, hemoglobin, platelets, D-dimer, C-reactive protein, LDH, and ferritin were measured and their correlation with the final patients' outcome was evaluated. A total of 208 patients were included in the present study. Higher neutrophil to lymphocyte ratio, (WBC count excluding lymphocyte)/lymphocyte, LDH, platelet to lymphocyte ratio, ferritin, and D-dimer were significantly related to O dependency. Neutrophil to lymphocyte ratio, (WBC count excluding lymphocyte)/lymphocyte and LDH were significantly related to higher rates of mortality. Higher Hb and lymphocyte count were significantly related to higher rates of survival. Hematological parameters including neutrophil to lymphocyte ratio, (WBC count excluding lymphocyte)/lymphocyte, LDH, platelet to lymphocyte ratio, ferritin, D-dimer, Hb, and lymphocyte count were significantly related to the prognosis of patients with COVID-19 disease. This could help decide which COVID-19 patients have priority for hospitalization and intensive medical care, particularly when the pandemic disease causes limitations in healthcare service.

摘要

自2019年以来,冠状病毒一直是一种高传染性疾病。2020年3月,世界卫生组织宣布新型冠状病毒肺炎(COVID-19)疫情为大流行。COVID-19患者报告了各种实验室检查结果,其中D-二聚体、乳酸脱氢酶水平升高以及淋巴细胞减少与需要呼吸机支持、入住重症监护病房和死亡率增加的疾病症状严重程度相关。在本研究中,纳入标准为:年龄在18岁以上且因COVID-19疾病入住伊玛目霍梅尼医院,经鼻咽拭子聚合酶链反应检测确诊。测量白细胞、中性粒细胞、淋巴细胞、血红蛋白、血小板、D-二聚体、C反应蛋白、乳酸脱氢酶和铁蛋白水平,并评估它们与患者最终结局的相关性。本研究共纳入208例患者。较高的中性粒细胞与淋巴细胞比值、(白细胞计数减去淋巴细胞数)/淋巴细胞数、乳酸脱氢酶、血小板与淋巴细胞比值、铁蛋白和D-二聚体与氧依赖显著相关。中性粒细胞与淋巴细胞比值、(白细胞计数减去淋巴细胞数)/淋巴细胞数和乳酸脱氢酶与较高的死亡率显著相关。较高的血红蛋白和淋巴细胞计数与较高的生存率显著相关。包括中性粒细胞与淋巴细胞比值、(白细胞计数减去淋巴细胞数)/淋巴细胞数、乳酸脱氢酶、血小板与淋巴细胞比值、铁蛋白、D-二聚体、血红蛋白和淋巴细胞计数在内的血液学参数与COVID-19疾病患者的预后显著相关。这有助于确定哪些COVID-19患者优先住院和接受重症医疗,特别是在大流行疾病导致医疗服务受限的情况下。